The skin is our primary interface towards the world, serving both as one of our main communication channels as well as being one of the most important protective barriers towards our surroundings.
Skin care products, topological drugs and medical treatments are all in need of enhanced testing procedures that, in an ethical agenda, can increase the transability from in vitro testing to in vivo usage of products. With tissue engineering and 3D bioprinting more representative in vitro models can be constructed, providing the possibility to limit the usage of animal models while increasing the physical relevance of the testing models.
The aim of the following project was to develop a full thickness skin tissue model comprised of CELLINK bioinks using the technique of 3D bioprinting. The study involved three major parts; design model based on literature, 3D bioprinting of different models and evaluation of the models.
CELLINK products used
Roger Guillemin identified the molecules in the brain that control the production of hormones in…
In 2007, Sinclair wrote the article “Healthy Hair: What is it?” in which he stated,…
We spoke to John Chave, director-general at trade body Cosmetics Europe, about changing regulations, what’s…